ARCHIVES

First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

New Therapeutic Approaches Improve Palliative Care

June 27, 2003

More Aggressive Prevention, Detection Could Save Lives, Cancer Policy Board Says

March 28, 2003

Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients

December 28, 2012

NCI-Approved Clinical Trials

October 29, 2004

Funding Opportunities: ONS Invites Applications For Instrumentation Grants on Fatigue

January 24, 1997

Komen Deal With KFC Yields Buckets Of Discord

April 23, 2010